Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation-Reference-Cited by-同舟云学术

Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation

Published:2004-01 Issue:5-6 Volume:22 Page:557-562
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Bonhoeffer Jan,Menkes John,Gold Michael S,de Souza-Brito Glacus,Fisher Margaret C,Halsey Neal,Vermeer Patricia

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference9 articles.

1. Seizures following childhood immunization;Hirtz;J. Pediatr.,1983

2. Haslam RH. The nervous system. In: Behrman RE, Kliegman RM, Arvin AM, editors. Nelson textbook of pediatrics. 15th ed. London: Saunders; 1996.

3. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for a revised clinical and encephalographic classification of epileptic seizures. Epilepsia 1981;22:489–501.

4. International League Against Epilepsy (ILAE). Task force on classification and terminology. Available at: http://www.epilepsy.org/ctf/seizure_frame.html.

5. Workshop on neurologic complications of pertussis and pertussis vaccination;Menkes;Neuropediatrics,1990

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Interoperable Computable Phenotype Algorithms for Adverse Events of Special Interest to Be Used for Biologics Safety Surveillance: Validation Study;JMIR Public Health and Surveillance;2024-07-15

2. A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB);Expert Review of Vaccines;2023-06-14

3. Development of Interoperable Computable Phenotype Algorithms for Adverse Events of Special Interest to Be Used for Biologics Safety Surveillance: Validation Study (Preprint);2023-06-09

4. Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial;The Lancet Infectious Diseases;2022-09

5. Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years;Pediatrics;2022-07-14